We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$115B
AUM Growth
+$6.24B
Cap. Flow
+$1B
Cap. Flow %
0.87%
Top 10 Hldgs %
23.71%
Holding
4,165
New
247
Increased
1,898
Reduced
1,581
Closed
296

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Healthcare 8.69%
3 Financials 8.53%
4 Industrials 6.69%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NNOX icon
3626
Nano X Imaging
NNOX
$73.2M
$109K ﹤0.01%
+18,860
New +$144K
IFRX icon
3627
InflaRx
IFRX
$296M
$109K ﹤0.01%
56,065
+14,942
+36% +$32.3K
BTA
3628
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
$109K ﹤0.01%
10,924
RMTI icon
3629
Rockwell Medical
RMTI
$30.9M
$108K ﹤0.01%
+5,982
New +$103K
MIRO
3630
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$108K ﹤0.01%
+64,300
New +$167K
GSAT icon
3631
Globalstar
GSAT
$10.7B
$107K ﹤0.01%
6,154
+333
+6% +$6.14K
CGC
3632
Canopy Growth
CGC
$426M
$107K ﹤0.01%
6,111
-657
-10% -$15.6K
SBDS
3633
DELISTED
Solo Brands Inc
SBDS
$107K ﹤0.01%
+372
New +$71.6K
FINV
3634
FinVolution Group
FINV
$1.07B
$104K ﹤0.01%
24,876
CDE icon
3635
Coeur Mining
CDE
$19B
$103K ﹤0.01%
25,900
-13,964
-35% -$48.5K
NHS
3636
Neuberger High Yield Strategies Fund Inc
NHS
$255M
$103K ﹤0.01%
12,079
-812
-6% -$6.94K
SCS
3637
DELISTED
Steelcase
SCS
$101K ﹤0.01%
12,044
+1,523
+14% +$11.7K
ABST
3638
DELISTED
Absolute Software Corp
ABST
$101K ﹤0.01%
12,950
+2,800
+28% +$27.3K
IAF
3639
abrdn Australia Equity Fund
IAF
$127M
$101K ﹤0.01%
7,699
+438
+6% +$6.16K
MQ icon
3640
Marqeta
MQ
$1.71B
$100K ﹤0.01%
5,477
-37
-0.7% -$826
MU icon
3641
CALL
Micron Technology
MU
$1.07T
$100K ﹤0.01%
+2,000
New +$117K
NKLA
3642
DELISTED
Nikola Corporation Common Stock
NKLA
$99.9K ﹤0.01%
2,751
+419
+18% +$27.5K
UWMC icon
3643
UWM Holdings
UWMC
$2.61B
$99.9K ﹤0.01%
20,337
+213
+1% +$934
TOON icon
3644
Kartoon Studios
TOON
$38.2M
$99.5K ﹤0.01%
36,451
-1,000
-3% -$4.55K
ASPS icon
3645
Altisource Portfolio Solutions
ASPS
$65.6M
$98.9K ﹤0.01%
+2,688
New +$130K
VMEO
3646
DELISTED
Vimeo
VMEO
$98.9K ﹤0.01%
25,817
-1,681
-6% -$6.59K
PSNY icon
3647
Polestar Automotive Holding UK
PSNY
$2B
$98.1K ﹤0.01%
863
+133
+18% +$20.2K
GANX icon
3648
Gain Therapeutics
GANX
$92.6M
$96.4K ﹤0.01%
20,000
-4,000
-17% -$16.4K
JRS icon
3649
Nuveen Real Estate Income Fund
JRS
$248M
$96.2K ﹤0.01%
12,873
-2,000
-13% -$16.2K
T icon
3650
PUT
AT&T
T
$168B
$94.5K ﹤0.01%
+6,300
New +$120K

Similar funds

Raymond James & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Raymond James & Associates held 4,165 positions worth $115B, up 5.7% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2023 filing shows 247 new, 1,898 increased, 1,581 reduced and 296 closed positions. Its largest new stake was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2023 buy was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2023, an estimated $413M increase.
  • Raymond James & Associates's biggest Q1 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $18.8M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $115B portfolio in Q1 2023.
  • Raymond James & Associates opened 247 new positions and closed 296 in Q1 2023.
  • Raymond James & Associates's portfolio value rose 5.7% quarter-over-quarter to $115B.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.